U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...

Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' ...

Cigna Healthcare, the health benefits division of the Cigna Group, has released a set of digital tools aimed at improving the ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future coverage decisions.

Amplify Weight Loss Drug & Treatment ETF THNR is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 51.9% from its 52-week low price of $18.56/share.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating headlines ...

In 2025, it feels like prescription weight-loss drugs have gone from mainstream to mania—we all know someone (or many someones) using them, and ads for different versions have taken over our ...

For those who are looking into using a weight loss drug, how fast they work often comes into question. While the timeline for noticeable changes varies from person to person, people have often ...

For people like Tina, whose insurance doesn’t cover the drug for weight loss use, discounts can bring the out-of-pocket price down to around $600 a month for the dose she needs. But that’s ...